Global neuromodulation in epilepsy market was valued at US$ 1365.89 million in 2018 and is expected to reach US$ 3410.12 million by 2027, growing at an estimated CAGR of 10.71% over the forecast period. Some of the players operating in the neuromodulation in epilepsy market are Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace, Inc. amongst others.Download...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian